FeesSafety
Pluang+

AllianceBernstein funds declare November distributions, with a notable increase for the National Municipal Income Fund.

Company Fundamentals
26 Oct 2026, 23:06 WIB
PRNewsWire
View Source
Bullish
AllianceBernstein funds declare November distributions, with a notable increase for the National Municipal Income Fund.

AllianceBernstein Closed-End Funds announced distributions for November 2026. The Global High Income Fund will pay $0.0655 per share, while the National Municipal Income Fund will distribute $0.067 per share, marking an increase of $0.01682 from its previous payout due to a new managed distribution policy. This policy aims for regular monthly payments but may include return of capital if distributions exceed income and gains. Shareholders are advised that distributions do not necessarily reflect fund performance and tax reporting details will follow.

AllianceBernstein Closed-End Funds announced distribution rates for November 2026, including a $0.067 per share payout increase for the National Municipal Income Fund. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 27, 2026 02:31 WIB: of 142 priced US Financials stocks, 88 rose and 51 fell. Notable movers include BSBR at USD 4.86 with a 1-day change of -12.43% and 0% Sell / 100% Buy order activity, CRCL at USD 79.39 down 7.59% with 0% Sell / 100% Buy, and WULF at USD 12.16 up 7.42% with 81% Sell / 19% Buy.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
23 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
23 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
35 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App